Skip to main content
. 2006 Nov 14;12(42):6786–6791. doi: 10.3748/wjg.v12.i42.6786

Figure 3.

Figure 3

The effects of IFN and ACE-I on the serum P-III-P in the patients with refractory chronic hepatitis C. A: P-III-P level before and after the study; B: % of change in the P-III-P level in each group. Control: untreated control group. ACE-I, IFN: ACE-I- and IFN-treated group, respectively. IFN + ACE-I: combination treated group with ACE-I and IFN. The data represent the means ± SD.